Loading...
Discovery of new biomarkers for malignant mesothelioma
Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been ap...
Na minha lista:
| Udgivet i: | Curr Pulmonol Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356891/ https://ncbi.nlm.nih.gov/pubmed/25927434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13665-015-0106-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|